During C. elegans morphogenesis, the embryo elongates from a bean to a worm shape within 3 hours, without any cell division. Elongation, which ultimately reduces embryo circumference and lenghthens its A-P axis by 4-fold, depends on 3 processes: 1- actomyosin tension 2- a mechanotransduction pathway between muscles and the epidermis 3- microtubules (MT). In 1986, J. Priess showed that treatments with MT-depolymerising drugs affect elongation, however how MT precisely act is still unknown. We address this question by inducing the expression of spastin -a MT-severing protein- in various cell types. We use an operon-like expression system in order to co-express the spastin protein (SPAS-1) with an mCherry reporter, and express it in all epidermal cells (
lin-26 promoter), in the lateral seam cells (P_ceh-16), in the dorso-ventral cells (P_elt-3 and P_dpy-7), or in all cells using a heat-shock promoter (hsp). MTs are indeed disrupted in mCherry-expressing cells, as visualised with a tubulin::GFP reporter. MT degradation is proportional to the dose of spastin expressed in the cells, the best results being obtained with the strong hsp and the
dpy-7 promoters. Besides, early SPAS-1 induction causes cell division defects in the early blastomeres, suggesting that MT function is efficiently disrupted. We found that embryonic lethality is higher with the hsp promoter vs any epidermal promoter (35% vs below 10%). Importantly, a deleted version of SPAS-1 did not cause lethality. Using videomicroscopy, we could define the time window in which SPAS-1 induction causes embryonic phenotypes, namely just before the onset of elongation. Interestingly, if SPAS-1 is induced after the lima-bean stage, it no longer affects morphogenesis. Similar results were observed when SPAS-1 was expressed under the
dpy-7 promoter, which becomes active after the onset of elongation; the embryos elongate normally although they lack MTs. However, MTs might provide some stiffness, since a transient and local bulge is often observed where they are degraded. Finally we found that the Rho kinase
let-502 mutants are hypersensitive to SPAS-1 expression, arguing that actomyosin tension could compensate for the lack of MTs. In parallel, to test if some genes required for elongation also affect MT dynamics, we have generated an integrated P_dpy-7::EB-1::GFP line. We observed that the MT growth rate is higher in seam cells than in dorso-ventral cells. Interestingly this difference is almost abolished in the
let-502 mutants, which are blocked in elongation and lack actomyosin tension. In conclusion, there would be a close link between actin and MTs in morphogenesis: i) actomyosin tension could compensate the lack of MTs in the epidermis, ii) MT growth rate in the seam cells depends on a normal actomyosin tension. Further tests should confirm or infirm this hypothesis.